KMKyle K. Millage

Kyle K. Millage

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kyle K. Millage has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Medical Modeling of Particle Size Effects for CB Inhalation Hazards

    by Kyle K. Millage, Gene E. McClellan, Bahman Asgharian, Joshua J. Bergman, Darren R. Oldson, Sharon A. Watson

    In this project, Applied Research Associates, Inc. (ARA) developed the Deposition And Response in the Respiratory Tract (DARRT) model; an improved medical model of particle size effects for inhalation hazards from chemical and biological (CB) agents. This project was initiated to improve modeling of the variation in human response caused by differences in particle sizes, in particular, for coarse particles that may be present near a dissemination source and may remain suspended long enough in an urban environment to expose large numbers of people. Plume dispersion calculations with the Defense Threat Reduction Agency's (DTRA's) Hazard Prediction and Assessment Capability (HPAC) show that, contrary to common beliefs, particles as large as 20 to 40 microns in diameter can be a significant hazard tens of kilometers downwind of a release. DARRT predicts the probability of infection or injury from inhalation exposure to aerosol hazards of CB agents with aerodynamic diameters between 0.01 and 100 microns and describes the resulting medical impact. Many current models assume that only the 1 to 5 micron respirable particles capable of reaching the pulmonary region of the respiratory system are of concern; however, we find that inclusion of coarse (greater than 5 micron) particle deposition is important, as well.

  • Open Access

    Cesium-137 Decorporation Model

    by Daniela Stricklin, Kyle K. Millage, Jason Rodriguez, Gene E. McClellan

    A treatment model for Cs-137 internal contamination by Prussian Blue was developed to evaluate efficacy of various treatment regimens. The model estimates Cs deposition, absorption, distribution, retention, excretion, and response to DTPA after an inhalation exposure. It estimates the acute red bone marrow and whole body effective dose as a function of time. Model results compare favorably with human and animal data. Outputs from the model include Cs deposition in the respiratory tract, distribution in tissue compartments over time with and without treatment, excretion rates, and radiation doses to critical organs. Calculations from the model may be used to analyze consequences of exposure to Cs and the effect of treatment.


  • Open Access

    Plutonium 238/239 Decorporation Model

    by Daniela Strickling, Jason Radriguez, Kyle K. Millage, Gene E. McClellan

    A treatment model for Pu-238/239 internal contamination by DTPA was developed to evaluate efficacy of various treatment regimens. The model estimates Pu deposition, absorption, distribution, retention, excretion, and response to DTPA after an inhalation exposure. It estimates the acute red bone marrow and lung doses and whole body effective dose as a function of time. Model results compare favorably with human and animal data. Outputs from the model include Pu deposition in the respiratory tract, distribution in tissue compartments over time with and without treatment, excretion rates, and radiation doses to critical organs. Calculations from the model may be used to analyze consequences of exposure to Pu and the effect of treatment.


  • A review of inhalability fraction models: discussion and recommendations

    by Kyle K. Millage, Josh Bergman, Bahman Asgharian, Gene McClellan

    The first step in mathematically modeling the mechanics of respiratory deposition of particles is to estimate the ability of a particle to enter the head, either through the mouth or nose. Models of the biological effects from inhaled particles are commonly, albeit incorrectly, simplified by making an assumption that the only particles of concern are those that can readily penetrate to the pulmonary region of the lung: typically particles less than 5 μm in aerodynamic diameter. Inhalability for particles of this size is effectively 100%, so there is little need to develop a mathematical representation of the phenomenon. However, chemical irritants, biological agents, or radioactive material, in the form of large particles or droplets, can cause adverse biological responses by simply being taken into the head and depositing in the extrathoracic area. As a result, it is important to understand the inhalability of both small and large particles. The concept of particle inhalability received little consideration until the 1970s; since then it has been the subject of many experiments with a fairly wide disparity of results, in part due to the variety of dependent variables and the difficulty in adequate measurement methods. This article describes the currently utilized models of inhalability, recommends specific methods for implementing inhalability into mathematical models of respiratory deposition, and identifies outstanding issues and limitations. In this article, we describe inhalability as it applies to particulate matter and liquid droplets; modeling the inhalability of fibers is a work in progress and is not addressed.


  • A review of inhalability fraction models: discussion and recommendations

    by Kyle K. Millage, Josh Bergman, Bahman Asgharian, Gene McClellan